It was demonstrated that combined treatment with ATR and CHK1 inhibitors leads to replication fork arrest, single-stranded DNA accumulation, replication collapse, and synergistic cell death in cancer cells in vitro and in vivo (73). The gene discussed is CHEK1; the disease is cancer.